Evidence map›Paper›PMID 22264928›Full record

ReviewCurrent opinion in immunology2012

Transcriptional drivers of the T-cell lineage program.

Ellen V Rothenberg

Open access · bronzeAbstract readReview
In one paragraph

Review in Current opinion in immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Feeder-cell-free system forFrontiers in immunology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Ellen V RothenbergDivision of Biology 156-29, California Institute of Technology, Pasadena, CA 91125, USA. evroth@its.caltech.edu
California Institute of Technology · US

Funding

Key nodes in the T-cell developmental gene regulatory networkR01AI095943 · NIAID · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ROTHENBERG, ELLEN V. · 2011 to 2015
$2.0M
Bcl11b in early T cell developmentR01AI083514 · NIAID · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ROTHENBERG, ELLEN V. · 2011 to 2015
$1.8M
Dynamic Epigenetic Mapping of a Stem Cell Differentiation ChoiceRC2CA148278 · NCI · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ROTHENBERG, ELLEN V., WOLD, BARBARA J · 2009 to 2010
$1.6M
NCI NIH HHS RC2 CA148278NCI NIH HHS RC2CA148278NIAID NIH HHS R01 AI083514NIAID NIH HHS R01AI083514NIAID NIH HHS R01 AI095943NIAID NIH HHS R01AI095943
6 · The paper itself

Abstract

The T-cell development program is specifically triggered by Notch-Delta signaling, but most transcription factors needed to establish T-cell lineage identity also have crossover roles in other hematopoietic lineages. This factor sharing complicates full definition of the core gene regulatory circuits required for T-cell specification. But new advances illuminate the roles of three of the most T-cell specific transcription factors. Commitment to the T-cell lineage is now shown to depend on Bcl11b, while initiation of the T-cell differentiation program begins earlier with the induction of TCF-1 (Tcf7 gene product) and GATA-3. Several reports now reveal how TCF-1 and GATA-3 are mobilized in early T cells and the pathways for their T-lineage specific effects.

Indexed as

Cell LineageAnimalsHumansPhenotypeSignal TransductionT-LymphocytesTranscription FactorsTranscription Factors

Identifiers

PMID22264928
PMCPMC3319509
OpenAlexW2024488862

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.